BC Platforms, a global leader in genomic data management and analytics today announced it is providing its world leading genomics platform, to Bumrungrad International, a multi-specialty hospital located in the heart of Bangkok, Thailand handling more than 1.1 million patients per year.
BC Platforms will be providing its customizable end-to-end Software-as-a-Service platform to enable Bumrungrad to offer personalized healthcare solutions for their patients in the clinic. The core system will be seamlessly integrated in the hospital infrastructure from laboratory to electronic patient record. Handling all types of genetic data from Genotype and NGS instruments to the clinical reporting needed to support the advanced patient care. Bumrungrad will also participate in providing its extensive Asian data and samples to BCRQUEST providing additional sample diversity and data resources for researchers. BCRQUEST is a global network of healthcare service providers and biobanks that provide genomic and clinical cohort data for pharmaceutical and medical research and development.
Artirat Charukitpipat, Chief Executive Officer at Bumrungrad, commented, “We are excited to be partnering with BC Platforms to bring personalized healthcare solutions into our clinical practice and research. We are looking forward to working with BC Platforms to set a new standard for predictive medicine complementing conventional treatment for our patients and clients across the globe.”
Tero Silvola, CEO of BC Platforms, said, “We are pleased that Bumrungrad has chosen to adopt our genomics platform for their clinical practice and to benefit research. We aim to build comprehensive collaboration programs with Bumrungrad to facilitate projects, where patients will benefit from the latest innovations and thereafter gain access to clinical trials relevant to their individual disease status. Bumrungrad is one of the largest healthcare providers in South East Asia and by contributing their data mainly focusing on Asian haplotypes to BCRQUEST we can greatly improve the diversity of our offering to research organizations worldwide.’
(0)
(0)Archive
- January 2021(47)
- December 2020(53)
- November 2020(59)
- October 2020(79)
- September 2020(72)
- August 2020(64)
- July 2020(71)
- June 2020(74)
- May 2020(50)
- April 2020(71)
- March 2020(71)
- February 2020(58)
- January 2020(62)
- December 2019(57)
- November 2019(64)
- October 2019(26)
- September 2019(24)
- August 2019(15)
- July 2019(24)
- June 2019(55)
- May 2019(82)
- April 2019(77)
- March 2019(71)
- February 2019(67)
- January 2019(77)
- December 2018(46)
- November 2018(48)
- October 2018(76)
- September 2018(55)
- August 2018(63)
- July 2018(74)
- June 2018(64)
- May 2018(65)
- April 2018(76)
- March 2018(82)
- February 2018(65)
- January 2018(80)
- December 2017(71)
- November 2017(72)
- October 2017(75)
- September 2017(65)
- August 2017(97)
- July 2017(111)
- June 2017(87)
- May 2017(105)
- April 2017(113)
- March 2017(108)
- February 2017(112)
- January 2017(109)
- December 2016(110)
- November 2016(121)
- October 2016(111)
- September 2016(123)
- August 2016(169)
- July 2016(142)
- June 2016(152)
- May 2016(118)
- April 2016(60)
- March 2016(86)
- February 2016(154)
- January 2016(3)
- December 2015(150)
